Skip to main content
SpringerLink
Log in

Interferon alfa-2a in the treatment of exudative age-related macular degeneration

  • Clinical Investigations
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Nineteen patiens (20 eyes) with the exudative form of macular degeneration were treated with parenteral interferon alfa-2a. Fifteen patients (16 eyes) had adequate follow-up for evaluation of outcome of the exudative macular lesion. The average follow-up was 8 months (range 5-11 months). Color photographs and fluorescein angiograms were evaluated independently by two masked readers for change in size, presence of fibrosis, and leakage of the neovascular lesion. During the follow-up, none of the exudative lesions resolved: one lesion became smaller, four remained the same, nine enlarged, and two could not be graded based on the photographs. Visual acuity remained 20/40 or better in four eyes. The proportion of eyes with visual acuity of 20/200 or worse increased from 35% at the initial visit to 59 % at the final visit. Ten patients experienced significant but reversible side effects, including weight loss, depression, and/or hematopoietic suppression. The data from these cases do not support any significant treatment benefit from interferon alfa-2a at the doses used in exudative macular degeneration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abrams DI, Volberding PA (1986) Alpha interferon therapy of AIDS-associated Kaposi's sarcoma. Semin Oncol 13 [Suppl 2]:43–47

    Google Scholar 

  2. Bressler NM, Frost LA, Bressler SB, et al. (1988) Natural course of poorly defined choroidal neovascularization associated with macular degeneration. Arch Ophthalmol 106:1537–1542

    Google Scholar 

  3. Brouty-Boyé D, Zetter BR (1980) Inhibition of cell motility by interferon. Science 208:516–518

    Google Scholar 

  4. Claessens DA, Miller JW, Woods WJ, Folkman J (1992) Alpha-interferon treatment of experimental choroidal neovascularization. ARVO abstracts. Invest Ophthalmol Vis Sci 33:1207

    Google Scholar 

  5. Folkman J (1989) Successful treatment of an angiogenic disease. N Engl J Med 320:1211–1212

    Google Scholar 

  6. Friesel R, Komoriya A, Maciag T (1987) Inhibition of endothelial cell proliferation by gamma-interferon. J Cell Biol 104:689–696

    Google Scholar 

  7. Fung WE (1991) Interferon Alpha 2a for treatment of agerelated macular degeneration. Am J Ophthalmol 112:349–350

    Google Scholar 

  8. Gass JDM (1984) Serous retinal pigment epithelial detachment with a notch: a sign of occult choroidal neovascularization. Retina 4:205–220

    Google Scholar 

  9. Heyns A duP, Elder A, Vlodavsky I, Kaiser N, Fridman R, Panet H (1985) The antiproliferative effect of interferon and the mitogenic activity of growth factors are independent cell cycle events. Studies with vascular smooth muscle cells and endothelial cells. Exp Cell Res 161:297–306

    Google Scholar 

  10. Lewis ML, Pautler S (1988) Retinal pigment epithelial detachments with choroidal neovascular membranes in age-related macular degeneration: natural history versus laser photocoagulation. In: Gitter KA, Schatz H, Yannuzzi LA, McDonald HR (eds) Laser photocoagulation of retinal disease. Pacific Medical Press, San Francisco, pp 207–216

    Google Scholar 

  11. Loughnan MS, Heriot WJ, O'Day J (1992) Treatment of subfoveal choroidal neovascular membranes with systemic interferon-α 2a. Aust NZ J Ophthalmol 20:173–175

    Google Scholar 

  12. Macular Photocoagulation Study Group (1991) Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 109:1220–1231

    Google Scholar 

  13. Singerman LJ, Stockfish JH (1989) Natural history of subfoveal pigment epithelial detachments associated with subfoveal or unidentifiable choroidal neovascularization complicating age-related macular degeneration. Graefe's Arch Clin Exp Ophthalmol 227:501–507

    Google Scholar 

  14. Soubrane G, Coscas G, Francais C, Koenig F (1990) Occult subretinal new vessels in age-related macular degeneration: natural history and early laser treatment. Ophthalmology 97:649–657

    Google Scholar 

  15. White CW, Sondheimer HM, Crouch EC, Wilson H, Fan LL (1989) Treatment of pulmonary hemangiomatosis with recombinant interferon alpha-2a. N Engl J Med 320:1197–1200

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami School of Medicine, 900 N.W. 17th Street, 33136, Miami, FL, USA

    Mary Lou Lewis, Janet Davis & Elaine Chuang

Authors
  1. Mary Lou Lewis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Janet Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elaine Chuang
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lewis, M.L., Davis, J. & Chuang, E. Interferon alfa-2a in the treatment of exudative age-related macular degeneration. Graefe's Arch Clin Exp Ophthalmol 231, 615–618 (1993). https://doi.org/10.1007/BF00921954

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00921954

Keywords

Search

Navigation